Walking and Cardio on a GLP-1

The number you will see everywhere is 150 minutes, and it is worth being precise about where it comes from, because it is not a GLP-1 number. The World Health Organization's Guidelines on Physical Activity and Sedentary Behaviour, published in 2020, recommend that adults aged 18 to 64 do at least 150 to 300 minutes of moderate-intensity aerobic activity a week, or 75 to 150 minutes of vigorous-intensity activity, or an equivalent mix, plus muscle-strengthening activity for all major muscle groups on two or more days a week. The Physical Activity Guidelines for Americans, second edition, from the U.S. Department of Health and Human Services, gives the same range and the same two-day strength floor, and adds "move more and sit less."

The WHO guidelines say plainly that some physical activity is better than none, and that adults not meeting the recommendation should start with small amounts and increase gradually. The HHS second edition removed its first edition's rule that only bouts of ten minutes or more counted; any amount of activity now counts.

Nothing in either guideline is specific to semaglutide, tirzepatide or liraglutide, and no FDA label, EMA product information or MHRA document sets an activity figure for these medicines. The Wegovy and Zepbound labels only describe the product as used in combination with a reduced-calorie diet and increased physical activity, without saying how much. So treat 150 to 300 minutes as orientation for an adult in general, and whatever your prescriber or physiotherapist says as the figure for you.

Weight lost during a calorie deficit is not purely fat; lean tissue, including muscle, generally comes down with it. In the STEP 1 trial of semaglutide published in the New England Journal of Medicine in 2021, the subgroup measured by DXA scanning lost both fat mass and lean body mass, with fat making up the larger share. The GLP-1 and muscle loss guide covers protein and resistance training in more depth.

Walking and other aerobic activity contribute to the weekly total the WHO and HHS guidelines describe. What walking does not do on its own is provide the stimulus muscle responds to. The two levers most consistently discussed for holding on to lean mass during weight loss are adequate protein and resistance training, and neither is replaced by more steps.

That is why this page and the strength training scenario sit side by side rather than competing. The unglamorous version for most people is walking most days because it is the activity you will actually do, two sessions a week of something that loads the major muscle groups because the guidelines ask for it, and protein given priority because appetite is the constraint. How that splits across your week is yours and your provider's to decide; a registered dietitian is the right person for a protein figure.

Fatigue is a listed adverse reaction on both of the main weight-management labels. Novo Nordisk's Wegovy prescribing information, revised June 2026, lists fatigue in 11 percent of adults on the injection versus 5 percent on placebo in the STEP trials. Eli Lilly's Zepbound prescribing information, revised August 2026, lists fatigue, which the label groups with asthenia, lethargy and malaise, at 5 to 7 percent across dose groups versus 3 percent on placebo. Those are trial rates, not a prediction for you.

On top of the label, there is arithmetic: eating much less means less fuel arriving, and a brisk walk on almost nothing tends to produce a poor walk and a flat afternoon. The GLP-1 fatigue guide sets out the overlapping causes, including the hypoglycemia consideration both labels raise for people who also take insulin or a sulfonylurea, which is a prescriber conversation before any exercise plan.

The WHO good-practice statement is the useful frame: start with small amounts and increase gradually. Four twenty-minute walks a week, repeated, are closer to what the guideline asks for, regular, gradual and sustainable, than one ninety-minute hike you regret.

What is not a lifestyle question: fatigue that is severe, persistent, unlike anything you have felt before, or accompanied by dizziness, palpitations or feeling faint. That is a call to your provider, not a shorter route.

Walking raises fluid loss through sweat at exactly the moment these medicines make hydration harder. The water scenario explains why: food normally supplies a meaningful share of daily water, meals are also drinking prompts, and reduced appetite and reduced thirst are frequently described together.

The labels treat dehydration as a clinical matter, not a wellness one. Both the Wegovy and the Zepbound prescribing information warn about acute kidney injury and note that most reported events occurred in patients whose gastrointestinal adverse reactions, such as nausea, vomiting or diarrhea, led to dehydration. That is a reason to skip the walk on a day when you are already nauseated or not keeping fluids down, and to call your provider rather than sweat it out.

The National Academies' adult reference intakes, roughly 2.7 liters a day of total water for women and 3.7 for men from all beverages and food combined, are population figures and not a target for you, and a prescribed fluid limit for a heart or kidney condition outranks everything here. The practical habits are ordinary: drink before you leave rather than only when you are back, carry water on anything longer than a short loop, and walk in the cooler part of a summer day.

A headache afterwards, light-headedness on standing, dark urine and unusual tiredness the same evening are signs a walk cost more than it should. None is a diagnosis; all belong in your notes for the next appointment.

The reason to write walks down is to answer, a few weeks from now, the questions you will otherwise guess at: do the flat days follow the dose day, is the scale stalling in the weeks you walked less, is protein falling on the days you moved more because you were too tired to eat?

A record that can answer those needs four things on the same page: the dose date, the morning weight, the day's protein, and a short note about activity. Minutes, a rough pace and how it felt is enough, plus anything else that happened that day.

This is the practical layer where GLP-1 Tracker fits. The app logs doses and dose days, keeps weight as a smoothed trend rather than a single alarming morning, estimates protein from a photo of a meal, and lets you attach a note to any day. There is no step counter, no workout log, no heart-rate data and no watch integration. A walk is a line in the notes, next to the rest of the day, so a pattern has somewhere to show up.

Give it four to six weeks before drawing any conclusion. "My energy is lowest on the two days after my dose, and those are the days I skipped walking" is a useful thing to say to a prescriber; "I think the medicine is making me tired" is a guess.

The app cannot tell you how much activity is right for you, cannot detect dehydration, cannot measure whether you are preserving muscle, and gives no medical guidance. Those answers belong to your provider.

The WHO good-practice statements are the safest starting instructions anyone will give you: some activity is better than none, start with small amounts, and increase frequency, intensity and duration gradually.

For most healthy adults, walking is the activity least likely to need clearance: the HHS guideline names brisk walking as its moderate-intensity example, and the WHO document says pre-exercise medical clearance is generally unnecessary for people without contraindications before light- or moderate-intensity activity not exceeding the demands of brisk walking or everyday living. A cardiac history, a joint problem, a recent surgery, diabetes managed with insulin or a sulfonylurea, or any medical reason you have been told to limit exertion is a reason to ask your provider what pace and duration make sense before you begin, and again after a dose increase if things change.

Walking on a GLP-1 is not a special case in the guidelines and a slightly special case in practice: the number is the same as for everyone; the fuel, the fluid and the fatigue are different. Plan for those three, write the walk down next to the dose, the weight and the protein, and let your provider read the pattern with you.